mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0005 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |